DFT studies of an anti-proliferative active spiro-oxindole against diverse tumor cell lines were reported.
No takes yet. Share an insight, caveat, or question.
Girgis et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: